EDPB publishes final version of guidelines on data transfers to third country authorities and SPE training material on AI and data protection

Brussels, 06 June – During its latest plenary, the European Data Protection Board (EDPB) adopted the final version of its guidelines on Art.48 GDPR about data transfers to third country authorities, after public consultation. In addition, the Board presented two new Support Pool of Experts (SPE) projects providing training material on artificial intelligence and data protection. … Read more

FTC Dismisses Lawsuit Against PepsiCo

The Federal Trade Commission today voted to dismiss without prejudice a Robinson-Patman Act (RPA) lawsuit against PepsiCo, Inc. (Pepsi) that was filed in the U.S. District Court for the Southern District of New York.View Press Release

Student Loan Debt Relief Scam Operators Agree to be Permanently Banned from Industry, Turn Over Assets to Resolve FTC Charges

FTC says operators falsely claimed affiliation with U.S. Department of Education, made false promises of loan forgiveness, and promoted fake reviews and testimonials The operators of an alleged transnational student loan debt relief scam have agreed to be permanently banned from the debt relief industry and to turn over more than $1 million in assets … Read more

FTC and DOJ File Statement of Interest in Energy Collusion Case Against BlackRock, State Street, and Vanguard

Statement argues asset managers misapply the antitrust laws in defending coal production collusion allegations that drove up energy prices for consumers The Federal Trade Commission, joined by the U.S. Department of Justice Antitrust Division, filed a Statement of Interest in a multistate antitrust case against asset managers BlackRock, State Street, and Vanguard. View Press Release

FTC Renews Challenge of More Than 200 Improper Patent Listings

Commission renews Orange Book listing disputes, marking third round of FTC challenges to promote affordable drugs, generic competition Continuing its efforts to promote competition and lower drug prices, today the Federal Trade Commission renewed its challenges against dozens of improperly listed device patents that shield brand-name asthma, diabetes, epinephrine autoinjector, and COPD drugs from prompt … Read more